Syndecan-1 in Acute Decompensated Heart Failure – Association With Renal Function and Mortality –

Abstract

The concentration of syndecan-1, a marker of glycocalyx damage measured during ED admission, is valuable in assessing the risk of developing AKI and in-hospital mortality. Its association with mortality is strong after 6-month follow-up.